Abstract

BackgroundDaboia siamensis (Eastern Russell’s viper) is a medically important snake species found widely distributed across Southeast Asia. Envenomings by this species can result in systemic coagulopathy, local tissue injury and/or renal failure. While administration of specific antivenom is an effective treatment for Russell’s viper envenomings, the availability of, and access to, geographically-appropriate antivenom remains problematic in many rural areas. In this study, we determined the binding and neutralizing capability of antivenoms manufactured by the Thai Red Cross in Thailand against D. siamensis venoms from four geographical locales: Myanmar, Taiwan, China and Thailand.Methodology/Principle findingsThe D. siamensis monovalent antivenom displayed extensive recognition and binding to proteins found in D. siamensis venom, irrespective of the geographical origin of those venoms. Similar immunological characteristics were observed with the Hemato Polyvalent antivenom, which also uses D. siamensis venom as an immunogen, but binding levels were dramatically reduced when using comparator monovalent antivenoms manufactured against different snake species. A similar pattern was observed when investigating neutralization of coagulopathy, with the procoagulant action of all four geographical venom variants neutralized by both the D. siamensis monovalent and the Hemato Polyvalent antivenoms, while the comparator monovalent antivenoms were ineffective. These in vitro findings translated into therapeutic efficacy in vivo, as the D. siamensis monovalent antivenom was found to effectively protect against the lethal effects of all four geographical venom variants preclinically. Assessments of in vivo nephrotoxicity revealed that D. siamensis venom (700 μg/kg) significantly increased plasma creatinine and blood urea nitrogen levels in anaesthetised rats. The intravenous administration of D. siamensis monovalent antivenom at three times higher than the recommended scaled therapeutic dose, prior to and 1 h after the injection of venom, resulted in reduced levels of markers of nephrotoxicity and prevented renal morphological changes, although lower doses had no therapeutic effect.Conclusions/SignificanceThis study highlights the potential broad geographical utility of the Thai D. siamensis monovalent antivenom for treating envenomings by the Eastern Russell’s viper. However, only the early delivery of high antivenom doses appears to be capable of preventing venom-induced nephrotoxicity.

Highlights

  • Snake envenoming is one of the world’s most lethal neglected tropical diseases, resulting in as many as 138,000 deaths per year [1]

  • The general trend, including at this dilution, revealed that the antibody-venom binding levels are highest when using the Hemato Polyvalent Snake antivenom (HPAV) and D. siamensis monovalent antivenom (DSAV) antivenoms, with both displaying considerably higher binding levels to the four different D. siamensis venoms than that of the TAAV and CRAV monovalent antivenoms. These results were anticipated, as D. siamensis venom is used as an immunogen for both the HPAV and the DSAV products

  • We demonstrate that the Thai monovalent and polyvalent antivenoms, i.e. DSAV and HPAV, exhibit extensive immunological binding and in vitro and in vivo neutralizing effects against D. siamensis venoms from Myanmar, Taiwan and China

Read more

Summary

Introduction

Snake envenoming is one of the world’s most lethal neglected tropical diseases, resulting in as many as 138,000 deaths per year [1]. One of the most medically important groups of venomous snakes are the Russell’s vipers (Viperidae: Daboia spp.). These relatively large, predominately nocturnal, snakes have a wide distribution across much of southern Asia [3] and have been classified into two species, the Western Russell’s viper (Daboia russelii) and the Eastern Russell’s viper (Daboia siamensis). Daboia siamensis (Eastern Russell’s viper) is a medically important snake species found widely distributed across Southeast Asia. Envenomings by this species can result in systemic coagulopathy, local tissue injury and/or renal failure. We determined the binding and neutralizing capability of antivenoms manufactured by the Thai Red Cross in Thailand against D. siamensis venoms from four geographical locales: Myanmar, Taiwan, China and Thailand

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call